US Patent Issued to EUSTRALIS PHARMACEUTICALS on Sept. 23 for "Parenteral formulations and uses thereof" (Australian Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,886, issued on Sept. 23, was assigned to EUSTRALIS PHARMACEUTICALS Ltd. (Melbourne, Australia).

"Parenteral formulations and uses thereof" was invented by Pierre Vankan (Melbourne, Australia), Andreea Sasarman (Melbourne, Australia) and Grasiela Bourscheit Willmbrink (Melbourne, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates generally to therapeutic parenteral formulations comprising particular substituted pyridine based compounds, their manufacture, and methods and uses of said formulations in treating elevated intracranial pressure for indications such as, but not limited to, traumatic brain injury and stroke."

T...